ANAL CANCER
Clinical trials for ANAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ANAL CANCER trials appear
Sign up with your email to follow new studies for ANAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells engineered to fight HPV tumors before standard care
Disease control Recruiting nowThis study tests whether a single dose of a patient's own genetically modified immune cells (E7 TCR-T cells) can shrink or eliminate HPV-related cancers before standard treatment like chemo-radiation or surgery. About 15 adults with advanced HPV-positive cancers (e.g., cervical, …
Matched conditions: ANAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated May 26, 2026 02:33 UTC
-
New combo therapy aims to beat back advanced anal cancer
Disease control Recruiting nowThis study tests whether giving a powerful chemotherapy (mDCF) before the usual chemoradiation can improve outcomes for people with advanced anal cancer that hasn't spread. About 310 adults with T3-4 or N1 stage disease will be randomly assigned to either standard treatment or th…
Matched conditions: ANAL CANCER
Phase: PHASE3 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated May 26, 2026 02:24 UTC
-
Supercharged immune cells take on HPV cancers
Disease control Recruiting nowThis study tests a new immunotherapy for people with advanced HPV-related cancers (cervical, throat, anal, and others). Doctors take a patient's own immune cells, add a special receptor to help them find and attack HPV-infected cancer cells, and give them back. The goal is to shr…
Matched conditions: ANAL CANCER
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated May 26, 2026 02:22 UTC
-
New combo therapy aims to wipe out early anal cancer without surgery
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy and radiation can completely eliminate early-stage anal cancer. About 23 adults with stage I to IIIA anal cancer will receive weekly chemo and radiation plus pembrolizumab, followed by m…
Matched conditions: ANAL CANCER
Phase: PHASE2 • Sponsor: Dustin Deming • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New hope for hard-to-treat cancers: drug shows promise in advanced HER2-positive tumors
Disease control Recruiting nowThis study looks at how well the drug T-DXd works in adults with advanced HER2-positive cancers that have spread and no longer respond to other treatments. About 100 people will take part, and researchers will track whether tumors shrink and how long the benefit lasts. The goal i…
Matched conditions: ANAL CANCER
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Simple dilator during radiation may prevent vaginal scarring in anal cancer patients
Symptom relief Recruiting nowThis study tests whether using a vaginal dilator during pelvic radiation therapy can reduce vaginal narrowing (stenosis) in women with anal cancer. About 60 women will be randomly assigned to use the dilator during radiation or not. The goal is to see if this simple approach lowe…
Matched conditions: ANAL CANCER
Phase: NA • Sponsor: Juergen Debus • Aim: Symptom relief
Last updated May 26, 2026 02:23 UTC
-
Virtual reality goggles could be new tool against cancer pain
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) can reduce severe belly pain and improve daily life in people with digestive tract cancers. 360 participants will be randomly assigned to one of three groups: skills-based VR, distraction VR, or a sham VR. The goal is to see if …
Matched conditions: ANAL CANCER
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Chinese study maps HPV's role in anal cancer
Knowledge-focused Recruiting nowThis study aims to find out which types of HPV are most common in anal cancer patients in China and describe the disease's impact. Researchers will collect data from 300 people diagnosed with anal cancer at multiple hospitals. The goal is to better understand the virus's role and…
Matched conditions: ANAL CANCER
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated May 26, 2026 02:33 UTC
-
Can a simple blood test predict cancer return? new study investigates
Knowledge-focused Recruiting nowThis study looks at whether HPV DNA can be found in the blood of people with HPV-related anal or cervical cancer before, during, and after radiation therapy. Researchers will collect blood samples and tumor tissue to see if changes in HPV DNA levels can help predict if the cancer…
Matched conditions: ANAL CANCER
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 26, 2026 02:31 UTC
-
New study aims to uncover hidden side effects of anal cancer treatment
Knowledge-focused Recruiting nowThis study looks at how radiotherapy for anal cancer affects women's vaginal and sexual health. Researchers will examine 80 women who completed treatment 6 to 36 months ago, using gynecological exams and questionnaires. The goal is to link radiation dose to vaginal problems and i…
Matched conditions: ANAL CANCER
Sponsor: Aarhus University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:27 UTC
-
HPV signatures may predict anal cancer risk a decade later
Knowledge-focused Recruiting nowThis study follows up with 100 people who took part in the ANRS IPERGAY trial to see how HPV infections relate to anal cancer risk over 10 years. Researchers will use special tests to find HPV molecular signatures and check for high-grade lesions or cancer. The goal is to better …
Matched conditions: ANAL CANCER
Phase: NA • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Knowledge-focused
Last updated May 26, 2026 02:27 UTC
-
New study aims to catch anal cancer early in High-Risk group
Knowledge-focused Recruiting nowThis study looks at anal cancer risk in men who have sex with men (MSM) who take PrEP to prevent HIV. Researchers want to find out how common high-grade anal lesions are in this group, how well anal swabs can detect them, and how these lesions affect quality of life. About 296 pa…
Matched conditions: ANAL CANCER
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated May 26, 2026 02:26 UTC
-
Scientists launch massive study to spy on immune cells in tumors
Knowledge-focused Recruiting nowThis study looks at immune cells (T cells) in tumor samples from 1,100 people with cancers like head and neck, ovarian, cervical, lung, and brain cancer. Researchers want to understand how these cells behave, especially a protein called PD-1. No new treatments are tested—only sam…
Matched conditions: ANAL CANCER
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 26, 2026 02:22 UTC
-
Self-Sampling could boost anal cancer screening in High-Risk groups
Knowledge-focused Recruiting nowThis study aims to see if allowing people at high risk for anal cancer to collect their own samples at home leads to more completed screenings. Researchers will compare attendance at follow-up appointments between those who self-sample and those who have a healthcare provider col…
Matched conditions: ANAL CANCER
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
Massive cancer registry aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study is creating a huge collection of medical information and biological samples from adults with or at risk for many types of cancer, as well as healthy volunteers. The goal is to help researchers better understand cancer causes, improve early detection, and develop person…
Matched conditions: ANAL CANCER
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC